https://novaprd-lb.newcastle.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:30962 Wed 11 Apr 2018 10:28:39 AEST ]]> Predicting Nasal High-Flow Treatment Success in Newborn Infants with Respiratory Distress Cared for in Nontertiary Hospitals https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:41976 Wed 08 Nov 2023 09:55:46 AEDT ]]> Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:52758 Thu 26 Oct 2023 12:05:26 AEDT ]]> Cost-effectiveness of Nasal High Flow versus CPAP for newborn infants in special-care nurseries https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:48837 1 hour were recruited during 2015–2017. Inpatient costing records were obtained for 753 infants, of whom 676 were included in the per-protocol analysis. Two scenarios were considered: (1) CPAP versus nHF, with infants in the nHF group having “rescue” CPAP backup available (trial scenario); and (2) CPAP versus nHF, as sole primary support (hypothetical scenario). Effectiveness outcomes were rate of endotracheal intubation and transfer to a tertiary-level NICU. Results: As sole primary support, CPAP is more effective and on average cheaper, and thus is superior. However, nHF with back-up CPAP produced equivalent cost and effectiveness results, and there is no reason to make a decision between the 2 treatments on the basis of the cost or effectiveness outcomes. Conclusions: Nontertiary special care nurseries choosing to use only 1 of the modes should choose CPAP. In units with both modes available, using nHF as first-line therapy may be acceptable if there is back-up CPAP.]]> Thu 13 Apr 2023 09:38:48 AEST ]]> Trends in the use of non-invasive respiratory support for term infants in tertiary neonatal units in Australia and New Zealand https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:50964 Mon 14 Aug 2023 15:18:35 AEST ]]> Supraglottic airway devices for administration of surfactant to newborn infants with respiratory distress syndrome: a narrative review https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:39809 Fri 24 Jun 2022 09:07:06 AEST ]]> Nasal high-flow therapy for newborn infants in special care nurseries https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:38591 Fri 21 Jan 2022 09:14:23 AEDT ]]>